Senators Tie Medicare Oral Drug Payment to Ending Markup on Infused Drugs
Bass & Howes Bought By DDB Seattle
Surgical Oncologists Honor HHS Secretary
Medical Adfances Not Driven Entirely By Science, Author Tells Journalists
Evidence Too Weak to Link Agent Orange, Cancer, IOM Says
IARC Says Evidence Supports Mammography Screening For 50-69, Limited Evidence For 40-49
Funding Opportunities.
Trending Stories
- FDA’s second rejection of Replimune’s melanoma treatment stirs worry among oncologists, patients
“Patients are owed another review.” - Mayo Clinic AI detects pancreatic cancer up to three years before diagnosis, validation study finds
- By adding specialists to USPSTF, Kennedy would reshape the functioning and decisions of the influential health panel
Ransohoff: “The task force’s job is to describe the evidence fairly, and that’s done best with objective, detached methodologists” - ASCO & The Conquer Cancer Foundation announce merit awards
- CDC’s recommendation to delay infant hepatitis B shot is likely to raise infections, JAMA studies show
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members









